Tenet Healthcare Corp (THC) 24.06 $THC Tenet to Present

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tenet Healthcare Corp (THC) 24.06 $THC

Tenet to Present at Investor Conferences in September
BusinessWire - Fri Sep 02, 9:30AM CDT
Tenet Healthcare Corporation (NYSE:THC) senior management will participate in the following investor conferences in September 2016:
THC: 24.06 (-0.14)

Why Tenet Healthcare (THC) Could Be Positioned for a Slump
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:37AM CDT
Tenet Healthcare has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off.
THC: 24.06 (-0.14), WOOF: 71.99 (+0.03)

Hospitals Stocks on Investors' Radar -- Community Health Systems, HCA Holdings, Tenet Healthcare, and Select Medical
PR Newswire - Mon Aug 22, 7:00AM CDT
Today's pre-market research on Stock-Callers.com brings investors back to the Hospitals industry which continues to struggle with labor costs. As per industry experts, wage inflation for private hospitals in the second quarter was the largest in eight years. Let us see how this has affected the performances of the following equities over the last few trading sessions: Community Health Systems Inc. (NYSE: CYH), HCA Holdings Inc. (NYSE: HCA), Tenet Healthcare Corp. (NYSE: THC), and Select Medical Holdings Corp. (NYSE: SEM). Learn more about these stocks by downloading their comprehensive and free reports at:
HCA: 76.15 (-0.36), THC: 24.06 (-0.14), CYH: 10.90 (+0.11), SEM: 12.03 (-0.09)

After Yesterday's Decline of 3.22%, Tenet Healthcare Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 17, 3:03PM CDT
Tenet Healthcare (NYSE:THC) traded in a range yesterday that spanned from a low of $24.19 to a high of $25.16. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $25.15 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
THC: 24.06 (-0.14)

SmarTrend Watching for Potential Rebound in Shares of Tenet Healthcare After 2.88% Loss
Comtex SmarTrend(R) - Thu Aug 11, 1:46PM CDT
Tenet Healthcare (NYSE:THC) traded in a range yesterday that spanned from a low of $25.13 to a high of $26.58. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $26.28 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
THC: 24.06 (-0.14)

Tenet Healthcare (THC) Q2 Earnings Miss, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:34AM CDT
Tenet Healthcare Corp. (THC) reported second-quarter 2016 operating earnings of 38 cents per share that missed the Zacks Consensus Estimate
HCA: 76.15 (-0.36), THC: 24.06 (-0.14), UHS: 119.67 (-1.03), ADPT: 43.56 (-1.28)

Tenet Reports Results for the Second Quarter Ended June 30, 2016
BusinessWire - Mon Aug 01, 4:07PM CDT
--Adjusted EBITDA was $617 million and Adjusted diluted earnings per share from continuing operations was $0.38.
THC: 24.06 (-0.14)

Peek Into Aug 1 Healthcare Stocks' Q2 Earnings: ADUS, THC
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 7:31AM CDT
Here, we take a sneak peek at two healthcare stocks scheduled to report their second-quarter figures on Aug 1.
THC: 24.06 (-0.14), ADUS: 24.61 (-0.26)

Is Tenet Healthcare (THC) Stock a Solid Choice Right Now?
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 7:47AM CDT
Tenet Healthcare (THC) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
THC: 24.06 (-0.14)

Philly jury awards $1.3 million in baby heart surgery death
Philly.com - Wed Jun 08, 8:06AM CDT
PHILADELPHIA (AP) — A Philadelphia jury has awarded $1.3 million to the estate of a days-old infant who died in 2011 after heart surgery at St. Christopher's Hospital for children.
THC: 24.06 (-0.14)

Technical Report on Hospitals Stocks -- HCA Holdings, Tenet Healthcare, Universal Health Services, and Select Medical Holdings
PR Newswire - Mon Jun 06, 7:45AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: HCA Holdings Inc. (NYSE: HCA), Tenet Healthcare Corporation (NYSE: THC), Universal Health Services Inc. (NYSE: UHS), and Select Medical Holdings Corporation (NYSE: SEM). Learn more about these stocks by accessing their free trade alerts at:
HCA: 76.15 (-0.36), THC: 24.06 (-0.14), UHS: 119.67 (-1.03), SEM: 12.03 (-0.09)

Tenet Healthcare Announces $100,000 Challenge Grant for 2016 Healthy Over Hungry Cereal Drive to Fight Against Hunger
BusinessWire - Wed Jun 01, 9:30AM CDT
Tenet Healthcare has announced a challenge grant of up to $100,000 to support its 2016 Healthy Over Hungry - Cereal Drive, an annual campaign designed to provide a healthy, well-balanced breakfast for children and families struggling with hunger during the summer months. The drive will be held June 3-10, 2016 in support of Feeding America and its nationwide network of local food banks and distribution partners.
THC: 24.06 (-0.14)

SmarTrend Watching for Potential Pullback in Shares of Tenet Healthcare After 1.58% Gain
Comtex SmarTrend(R) - Fri May 27, 3:12PM CDT
Tenet Healthcare (NYSE:THC) traded in a range yesterday that spanned from a low of $28.36 to a high of $29.27. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $29.03 on volume of 427,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
THC: 24.06 (-0.14)

After Yesterday's Decline of 1.59%, Tenet Healthcare Offers Investors Better Value
Comtex SmarTrend(R) - Mon May 23, 3:26PM CDT
Tenet Healthcare (NYSE:THC) traded in a range yesterday that spanned from a low of $26.97 to a high of $27.93. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $27.59 on volume of 629,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
THC: 24.06 (-0.14)

Tenet to Participate in the UBS Global Healthcare Conference on May 23, 2016
BusinessWire - Wed May 18, 9:32AM CDT
Tenet Healthcare Corporation (NYSE:THC) will participate in the UBS Global Healthcare Conference in New York on Monday, May 23, 2016. Senior management will speak at the conference at approximately 9:00 a.m. ET.
THC: 24.06 (-0.14)

Tami Brewer Named Executive Vice President of Engagement at Pure Moxie
PR Newswire - Fri May 06, 2:20PM CDT
Tami Brewer has been named Executive Vice President of Engagement at Pure Moxie, a brand innovation firm based in Napa, California.
THC: 24.06 (-0.14)

Downgrade Alert for Tenet Healthcare (THC)
Comtex SmarTrend(R) - Thu May 05, 3:23AM CDT
Tenet Healthcare (NYSE:THC) was downgraded from Buy to Neutral at Mizuho today. The stock closed yesterday at $31.47 on volume of 1.9 million shares, below average daily volume of 2.5 million. Tenet Healthcare Corporation, through its subsidiaries, owns or operates general hospitals and related health care facilities serving communities in the United States. The Company operates rehabilitation hospitals, specialty hospitals, long-term care facilities, psychiatric facilities, and medical office buildings near its general hospitals, as well as ancillary health care businesses.
THC: 24.06 (-0.14)

Tenet to Participate in the Bank of America Merrill Lynch 2016 Health Care Conference on May 10, 2016
BusinessWire - Wed May 04, 9:30AM CDT
Tenet Healthcare Corporation (NYSE:THC) will participate in the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas on Tuesday, May 10, 2016. Senior management will speak at the conference at approximately 11:40 a.m. ET (8:40 a.m. PT).
THC: 24.06 (-0.14)

Tenet Healthcare (THC) Q1 Earnings Beat Estimates, Up Y/Y
Zacks Equity Research - Zacks Investment Research - Tue May 03, 7:40AM CDT
Tenet Healthcare Corp. (THC) reported first-quarter 2016 operating earnings of 45 cents per share that outperformed the Zacks Consensus Estimate of 33 cents by 36.4%.
CI: 127.58 (-0.60), THC: 24.06 (-0.14), UNH: 135.97 (-0.64), AET: 116.37 (-0.36)

Q1 Earnings Season Heavy into Final Turn: AIG, APC, THC & QLYS
Mark Vickery - Zacks Investment Research - Mon May 02, 5:45PM CDT
Today after the bell, we had AIG (AIG), Anadarko (APC), Tenet Heathcare (THC) and Qualys (QLYS).
THC: 24.06 (-0.14), QLYS: 36.28 (+0.75), AIG: 59.45 (-0.41), APC: 57.19 (+0.70)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading